You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nilotinib

Showing 51 - 75 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

Terminated
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

Chronyc Myeloid Leukemia Trial in Italy, Netherlands (Imatinib, Nilotinib)

Active, not recruiting
  • Chronyc Myeloid Leukemia
  • Alessandria, Italy
  • +81 more
Jan 4, 2022

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
  • Nilotinib
  • Linz, Oberoesterreich, Austria
  • +207 more
Jun 23, 2021

Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia Trial in France, Germany, Spain (Nilotinib)

Completed
  • Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia
  • Nilotinib
  • Aix-en-Provence cedex 1, France
  • +68 more
Jul 29, 2020

Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia Trial in Paris (Nilotinib, Methotrexate, Aracytine (Ara C))

Recruiting
  • Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia
  • Nilotinib
  • +8 more
  • Paris, France
    Hopital Saint Louis
Oct 18, 2019

Leukemia Trial in China (Imatinib, Nilotinib)

Completed
Has Results
  • Leukemia
  • Guangzhou, Guangdong, China
  • +11 more
Jul 11, 2019

Chronic Myeloid Leukemia Trial in Germany (Imatinib, Nilotinib)

Terminated
  • Chronic Myeloid Leukemia
  • Aachen, Germany
  • +17 more
Nov 27, 2019

Chronic Myeloid Leukemia Trial in Germany (Nilotinib, Ruxolitinib)

Completed
  • Chronic Myeloid Leukemia
  • Berlin, Germany
  • +3 more
Apr 29, 2019

Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,

Completed
Has Results
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +9 more
  • Denver, Colorado
  • +2 more
Jan 17, 2020

CML Trial in United States (nilotinib)

Completed
Has Results
  • CML
  • nilotinib
  • Birmingham, Alabama
  • +53 more
Feb 25, 2020

Myelogenous Leukemia, Chronic Trial in Worldwide (nilotinib, imatinib)

Completed
Has Results
  • Myelogenous Leukemia, Chronic
  • Los Angeles, California
  • +212 more
Oct 23, 2020

Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Leukemia Trial in Atlanta (Dasatinib, Imatinib Mesylate, Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Nov 1, 2018

Patients Who Have Received Allo-HSCT Trial in Taipei (nilotinib)

Completed
  • Patients Who Have Received Allo-HSCT
  • nilotinib
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 10, 2018

Mucosal Lentiginous Melanoma, Acral Melanoma, Melanoma Trial in United States (Nilotinib)

Completed
Has Results
  • Mucosal Lentiginous Melanoma
  • +2 more
  • Nilotinib
  • Santa Monica, California
  • +7 more
Oct 16, 2018

Leukemia Trial in Worldwide (drug, genetic, other)

Completed
  • Leukemia
  • nilotinib
  • +4 more
  • San Antonio, Texas
  • +5 more
Jul 23, 2018

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • +3 more
  • Nilotinib
  • Duarte, California
  • +100 more
Jun 8, 2021

Chronic Myeloid Leukemia Trial in Italy (Nilotinib)

Completed
  • Chronic Myeloid Leukemia
  • Nilotinib
  • Ancona, Italy
  • +33 more
Aug 3, 2018

Chronic Myeloid Leukemia, Chronic Phase Trial (Nilotinib)

Completed
  • Chronic Myeloid Leukemia, Chronic Phase
  • Nilotinib
  • (no location specified)
Nov 1, 2017

Colon Cancer Trial in Bordeaux (Nilotinib)

Withdrawn
  • Colon Cancer
  • Nilotinib
  • Bordeaux, France
    Institut Bergonié
Oct 4, 2017

Philidelphia Positive Chronic Myeloid Leukaemia Trial in Australia (Nilotinib)

Terminated
Has Results
  • Philidelphia Positive Chronic Myeloid Leukaemia
  • Nilotinib
  • Canberra, Australian Capital Territory, Australia
  • +13 more
Sep 26, 2017

Mucosal Lentiginous Melanoma, Acral Lentiginous Malignant Melanoma Trial in London (nilotinib)

Completed
  • Mucosal Lentiginous Melanoma
  • Acral Lentiginous Malignant Melanoma
  • nilotinib
  • London, United Kingdom
    Royal Marsden NHS Foundation Trust
Jun 7, 2017

Chronic Myeloid Leukaemia Trial in Liverpool (Imatinib, nilotinib, dasatinib)

Unknown status
  • Chronic Myeloid Leukaemia
  • Liverpool, United Kingdom
    University of Liveprool
May 3, 2017

CML, Nilotinib, Imatinib Resistant Trial in Seoul (nilotinib)

Completed
  • CML
  • +3 more
  • nilotinib
  • Seoul, Korea, Republic of
    St. Mary hospital, Catholic medical center
Feb 24, 2017